After Dropping AstraZeneca From Its Vaccine Plan, the Africa CDC Looks to Sinopharm For Jabs

The Africa Center for Disease Control is reportedly in “advanced stage of discussions” to secure supplies of the Chinese-made Sinopharm vaccine. “We are hopeful the discussion will lead to a favorable pronouncement on the emergency use authorization of Sinopharm’s coronavirus vaccine. This will increase the pool of our recommended vaccines,” said Dr. John Nkengasong, the director of the Africa CDC at a press briefing late last week

This is a bit of a surprise. Until now the Africa CDC had focused on purchasing AstraZeneca (AZ) and Johnson & Johnson jabs. However, two weeks ago, the CDC said it dropped AZ from its plan due to ongoing supply constraints from India where the vaccine is manufactured. 

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.